Sam has over 10 years of experience in drug development in oncology, liver, and rare diseases. He became interested in clinical research during his master’s program at Columbia University, exploring cardiovascular risk factors among HIV patients in Nairobi, Kenya. Prior to joining SonALAsense, he held positions at UCSF Porphyria Center, Gilead Sciences, Dynavax Technologies, Nektar Therapeutics and BridgeBio.